Clinical Trial Update: PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors [Phase 1, Phase 2]

View source ↗

Summary

The trial investigated PLX3397 plus sirolimus in unresectable sarcoma and malignant peripheral nerve sheath tumor; the study was terminated, and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Peripheral Nerve Sheath Tumor
• Sarcoma

Drugs mentioned

• PLX3397 (PLX3397)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Gulam Manji | Conditions: Sarcoma, Malignant Peripheral Nerve Sheath Tumors | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-03-21